Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …

LL37 exerts a dual pathogenic role in psoriasis. Bound to self-DNA/RNA, LL37 licenses
autoreactivity by stimulating plasmacytoid dendritic cells-(pDCs)-Type I interferon (IFN-I) and …

Objective The autoimmune etiology in psoriasis remains to be clarified. We therefore
undertook this study to identify novel pathogenic autoantigens and autoantibodies in …

Psoriasis is a common T-cell-mediated skin disease with 2–3% prevalence worldwide.
Psoriasis is considered to be an autoimmune disease, but the precise nature of the …

Cathelicidin LL-37 is an antimicrobial peptide that is synthesized by epithelial cells,
neutrophils, or lymphocytes and act as an essential defense mechanism against bacterial …

Psoriasis is a common immune‐mediated disease that affects 2%‐4% of individuals in North
America and Europe. In the past decade, advances in research have led to an improved …

In the past decades, clinical and experimental evidence has demonstrated that psoriasis is
an immune‐mediated inflammatory disease of the skin that occurs in genetically susceptible …

Psoriasis is an (auto) immune-mediated disease that manifests as widespread
desquamative erythema. The TNF-α/IL-23/IL-17A axis is crucial to its pathogenesis, which is …

Arthritis is a common clinical feature of systemic lupus erythematosus (SLE) and is usually
non-erosive, as opposed to rheumatoid arthritis (RA). While RA synovial pathology has been …

Psoriatic arthritis (PsA) is a chronic inflammatory skin disease that causes enthesitis and
destructive arthritis and significantly lowers patient quality of life. Recognition of the two …